Alteration of IKZF1 is also associated with poor outcome in BCR-ABL1-negative ALL [27, 29–31], where this association is independent of commonly used risk stratification features such as age, sex, white cell count, and levels of minimal residual disease (MRD). Here, IKZF1 is linked to acute lymphoblastic leukemia.